• Type 135 hosts world‑first deployment of Horse Powertrain’s W40 V8 paired with HORSE 8LDCT hybrid dual‑clutch gearbox.
  • Type 135 is Lotus’ all-new mid-engine hybrid-V8 supercar. It’s the brand’s first entry into the category between Emira and Evija.
  • HORSE W40, Horse Powertrain’s first production-ready V8 engine, is one of the most power-dense V8 solutions available on the market today. It can achieve peak output of over 500kW, with maximum torque of 800Nm and designed for integration with HORSE 8LDCT transmission, an eight-speed dual-clutch hybrid transmission with a maximum torque of 1,050Nm.

NEW YORK, Nov. 11, 2026 (GLOBE NEWSWIRE) — Lotus Technology Inc. (Nasdaq: LOT) (“Lotus Tech” or the “Company”), a leading global intelligent and luxury mobility provider, today announced a partnership with Horse Powertrain, a global leader in innovative and low-emission powertrain systems, that the newly revealed HORSE W40 V8 engine and HORSE 8LDCT transmission will make their world debut as an integrated hybrid powertrain set in the forthcoming Lotus Type 135.

Type 135 represents the next chapter in Lotus sports car performance. Bringing together the brand’s renowned focus on driver engagement with an advanced V8 hybrid powertrain, it has been engineered to set a new benchmark for Lotus sports cars. The model preserves the emotional connection Emira owners have with Lotus’ mechanical handling, while leveraging V8 hybrid technology to approach the technical benchmark set by Evija. As the Lotus lifestyle vehicle portfolio continues to broaden its customer base, the Type 135 will simultaneously further strengthen the performance and design DNA that Lotus has been renowned for more than 70 years.

HORSE W40 is a 4.0L, 8-cylinder engine optimized for high-performance hybrid vehicle platforms. HORSE W40 is one of the most power-dense V8 solutions available on the market today – weighing just 200kg, its peak power output is over 500kW with a maximum torque of 800Nm. The engine’s ability to deliver exceptional low-end torque and high peak power makes it an ideal solution for sports cars, pick-up trucks, and off-road vehicles.

To complement HORSE W40 and cement it as the leading hybrid engine for top-end vehicles, Horse Powertrain has developed the HORSE 8LDCT transmission. This eight-speed transmission features a sportscar-grade wet dual clutch, achieving a world-class pre-fill time of <50ms and delivering a shift response of <20ms. Featuring a built-in silicon carbide control system and power module, along with a variable-displacement mechanical pump, HORSE 8LDCT supports a peak torque input of up to 1,050Nm.

Feng Qingfeng, CEO of Lotus Tech, said: “We are excited to partner with Horse Powertrain to bring its advanced V8 engine and hybrid transmission technology to the upcoming Lotus Type 135. HORSE W40 and HORSE 8LDCT both represent significant advances in powertrain engineering, combining exceptional power and torque density with a highly integrated design. By bringing these technologies together with Lotus’ expertise in lightweight engineering and chassis dynamics, we aim to deliver a new generation of supercar performance, combining outstanding power, efficiency, and the precise, engaging driving experience that defines Lotus.”

Matias Giannini, CEO of Horse Powertrain, said: “HORSE W40 marks another landmark achievement for Horse Powertrain’s engineering teams, with our world-class technology powering one of the most power-dense V8s in automotive history. This hybrid-first engine has been built with our company’s full-powertrain perspective and expertise, designed for integration from the outset with our landmark HORSE 8LDCT transmission. In powering the Lotus Type 135, Horse Powertrain is both advancing the state of the art of automotive engineering while making a historic contribution to the world-renowned Lotus brand.”

About Lotus Technology Inc.

Lotus Technology Inc. has operations across the UK, the EU, the US and China. The Company is dedicated to delivering high-performance sports cars and luxury lifestyle electric vehicles under Lotus Brand, a global performance brand built on solid foundations and a rich heritage, with a focus on world-class R&D in next-generation automobility technologies and designs to meet its uncompromising vision of how a car should look, perform and feel. For more information about Lotus Technology Inc., please visit www.group-lotus.com.

About Horse Powertrain

Horse Powertrain is a global leader in innovative, low-emission hybrid and combustion powertrain solutions, supporting automotive OEMs with a range of systems including engines, transmissions, power electronics, range extenders, and integrated hybrid platforms. Horse Powertrain has operations in Europe, China, and the Americas, and employs over 19,000 people across 18 plants and five R&D centers. Its 25 customers include Renault Group, Geely Auto, Volvo Cars, Proton, Nissan, and Mitsubishi Motors Corporation. Horse Powertrain is headquartered in London, UK.

Forward-Looking Statements

This press release contains statements that may constitute “forward-looking” statements pursuant to the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact are forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “may”, “should”, “expect”, “intend”, “will”, “estimate”, “anticipate”, “believe”, “predict”, “potential”, “forecast”, “plan”, “seek”, “future”, “propose” or “continue”, or the negatives of these terms or variations of them or similar terminology although not all forward-looking statements contain such terminology. Forward-looking statements involve inherent risks and uncertainties, including those identified under the heading “Risk Factors” in the Company’s filings with the U.S. Securities and Exchange Commission. All information provided in this press release is as of the date of this press release, and Lotus Tech undertakes no obligation to update any forward-looking statement, except as required under applicable law.

Contact Information

For investor inquiries

ir@group-lotus.com

TAICHUNG CITY, Taiwan, Nov. 11, 2026 (GLOBE NEWSWIRE) — J-Star Holding Co., Ltd. (Nasdaq: YMAT) (“J-Star” or the “Company”), an innovator in advanced composite manufacturing, today issued a corporate update aimed at aligning timelines with Tier 1 carbon fiber suppliers, highlighting management’s financial commitment, and detailing the collaboration between both parties on local U.S. production of drone airframes.

Jointly Building Strategic Cooperation and Investment Frameworks for Each Party

As part of the preliminary preparations for upcoming strategic meetings and facility visits with Japanese multinational Tier 1 carbon fiber suppliers, J-Star’s Taiwan R&D head is traveling to Houston to participate in detailed discussions and advance pre-meeting coordination. J-Star will detail key operational milestones and investment frameworks for future collaboration, while both parties coordinate the necessary investments and timelines for the U.S. supply of Tier 1 carbon fiber raw materials, alongside expanded supply chain investments in the United States, to ensure a robust, adequate, and timely flow of materials.

Substantial Executive Financial Commitment

Demonstrating strong collaboration and mutual rapport with our raw material suppliers, J-Star’s management detailed the implementation of significant balance sheet strengthening initiatives. As previously disclosed, Chairman and Chief Executive Officer Jonathan Chiang has personally converted $8.2 million of debt into equity, alongside an additional $1.7 million in debt cancellation. This decisive action substantially improves the Company’s financial structure and further aligns executive interests with those of public shareholders.

About J-Star Holding Co., Ltd.

J-Star Holding Co., Ltd. (Nasdaq: YMAT) develops and commercializes cutting-edge technology in carbon reinforcement and resin systems. The company is a global manufacturer of carbon fiber and composite material products, with a legacy in high-performance cycling components and a growing portfolio of applications across healthcare, automotive, and other advanced materials markets. Headquartered in Taichung, Taiwan, J-Star is backed by 50 years of industrial manufacturing experience with IP technology developed to facilitate its expansion into United States. For more information, visit j-starholding.com.

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, including statements regarding the Company’s capital markets strategy, its U.S. expansion plans, and its evaluation of opportunities in aerospace and defense-adjacent markets. These statements are based on current expectations and assumptions and are subject to risks and uncertainties that could cause actual results to differ materially, including those described in the Company’s filings with the U.S. Securities and Exchange Commission, including its Annual Report on Form 20-F and its registration statement on Form F-3, as amended. The Company undertakes no obligation to update any forward-looking statements, except as required by law.

Contact

Matt Chesler, CFA
FNK IR
646-809-2183
investor@j-starholding.com

NOVATO, Calif., Nov. 11, 2026 (GLOBE NEWSWIRE) — Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for serious rare and ultra-rare genetic diseases, today announced participation in upcoming investor conferences.

UBS Global Biopharma Conference 2026

  • Monday, November 16, 2026, Emil Kakkis, M.D., Ph.D., President and Chief Executive Officer, Eric Crombez, M.D., Chief Medical Officer, and Howard Horn, Chief Financial Officer, will participate in a fireside chat and host 1×1 meetings.

2026 Jefferies Global Healthcare Conference

  • Tuesday, November 17, 2026, Emil Kakkis, Eric Crombez, and Howard Horn will participate in a fireside chat and host 1×1 meetings.

The live and archived webcast of the fireside chat will be accessible from the company’s website at https://ir.ultragenyx.com/events-presentations.

About Ultragenyx

Ultragenyx is a biopharmaceutical company committed to bringing novel products to patients for the treatment of serious rare and ultra-rare genetic diseases. The company has built a diverse portfolio of approved therapies and product candidates aimed at addressing diseases with high unmet medical need and clear biology for treatment, for which there are typically no approved therapies treating the underlying disease.

For more information on Ultragenyx, please visit the company’s website at: www.ultragenyx.com.

Contacts – Ultragenyx
Investors
Joshua Higa
ir@ultragenyx.com

VANCOUVER, British Columbia, Nov. 11, 2026 (GLOBE NEWSWIRE) — LEEF Brands Inc. (CSE: LEEF) (OTCQB: LEEEF) (“LEEF” or the “Company”) today announced that it will release its financial results for the third quarter ended September 30, 2026, after market close on Thursday, November 19, 2026.

The Company will host a conference call to discuss the results at 5:00 p.m. Eastern Time on the same day. The call will be led by Micah Anderson, Chief Executive Officer, Kevin Wilson, Chief Financial Officer, and Jesse Redmond, Chief Strategy & Investor Relations Officer.

Conference Call Details
Date: Thursday, November 19, 2026
Time: 5:00 p.m. Eastern Time
Webcast: To listen live and access the replay, please visit: https://edge.media-server.com/mmc/p/knob8zwr

About LEEF Brands Inc.
LEEF Brands Inc. is a leading California concentrate company. With a comprehensive supply chain, innovative manufacturing processes, a dynamic bulk concentrate portfolio, and a growing line of branded products, LEEF powers some of the largest cannabis brands in the United States. For more information, visit www.leefbrands.com.

Forward-Looking Statements
This news release contains certain forward-looking information and forward-looking statements, as defined in applicable securities laws (collectively, “forward-looking statements”), including, but not limited to, statements regarding the Company’s future financial condition, operations, and objectives.

Forward-looking statements reflect current expectations or beliefs regarding future events or the Company’s future performance or financial results. All statements other than statements of historical fact are forward-looking statements.

Often, but not always, forward-looking statements can be identified by the use of words such as “plans”, “expects”, “is expected”, “budget”, “scheduled”, “estimates”, “continues”, “forecasts”, “projects”, “predicts”, “intends”, “anticipates”, “targets” or “believes”, or variations of, or the negatives of, such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “should”, “might” or “will” be taken, occur or be achieved.

All forward-looking statements, including those herein, are qualified by this cautionary statement.

Although the Company believes that the expectations expressed in such statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in the statements.

There are certain factors that could cause actual results to differ materially from those in the forward-looking information, including, but not limited to, the risks disclosed in the Company’s public filings on the Company’s issuer profile on SEDAR+ at www.sedarplus.ca and on EDGAR at www.sec.gov. Accordingly, readers should not place undue reliance on forward-looking statements.

Contact
LEEF Brands Inc.
Jesse Redmond
Chief Strategy & Investor Relations Officer
Phone: +1 (805) 717-9327
Email: ir@leefca.com

THE WOODLANDS, Texas, Nov. 11, 2026 (GLOBE NEWSWIRE) — Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a leading cardiometabolic biopharmaceutical company, today announced that Company management will participate in a fireside chat at the 2026 Jefferies Global Healthcare Conference on Wednesday, November 18, 2026, at 8:00 a.m. GMT in London.

The live event and a replay of the presentation can be accessed via the Events page of the Company’s website at https://investors.lexpharma.com/.

About Lexicon Pharmaceuticals 

Lexicon Pharmaceuticals is a biopharmaceutical company pursuing novel medicines for patients with serious cardiometabolic diseases. Building on a proven legacy in genetic target discovery, Lexicon is advancing a clinical pipeline in areas of significant and often underserved need, with programs in hypertrophic cardiomyopathy (HCM), type 1 diabetes (T1D), obesity and other related metabolic conditions. Lexicon is committed to developing differentiated therapies that can be integrated broadly into clinical practice, with the goal of expanding treatment options for patients. Its capabilities extend from early-stage target discovery through clinical development and commercialization, strategically paired with high-impact collaborations to maximize the global reach of its medicines.

For additional information, please visit www.lexpharma.com.   

For Media Inquiries:
Dave Belian
Lexicon Pharmaceuticals, Inc.
lexinvest@lexpharma.com

For Investor Inquiries:
Lisa DeFrancesco
Lexicon Pharmaceuticals, Inc.
lexinvest@lexpharma.com

WILMINGTON, Del., Nov. 11, 2026 (GLOBE NEWSWIRE) — InterDigital, Inc. (Nasdaq: IDCC), a wireless, video and AI technology research and development company, today announced that the company will be presenting at two upcoming investor conferences:

  • RBC Capital Markets Technology, Internet, Media & Telecommunications Conference on November 17th, 2026, at 10:00 AM ET.
  • NASDAQ London Investor Conference on December 8th, 2026 at 11:00 AM ET.

These events will be webcast live and an archived replay of the presentations will also be available following the conferences. For more information, please visit the Investors section of the company’s website closer to the event.

About InterDigital®

InterDigital is a global research and development company focused primarily on wireless, video, artificial intelligence (“AI”), and related technologies. We design and develop foundational technologies that enable connected, immersive experiences in a broad range of communications and entertainment products and services. We license our innovations worldwide to companies providing such products and services, including makers of wireless communications devices, consumer electronics, IoT devices, cars and other motor vehicles, and providers of cloud-based services such as video streaming. As a leader in wireless technology, our engineers have designed and developed a wide range of innovations that are used in wireless products and networks, from the earliest digital cellular systems to 5G and today’s most advanced Wi-Fi technologies. We are also a leader in video processing and video encoding/decoding technology, with a significant AI research effort that intersects with both wireless and video technologies. Founded in 1972, InterDigital is listed on Nasdaq.

InterDigital is a registered trademark of InterDigital, Inc.

For more information, visit: www.interdigital.com.

InterDigital Contact:
investor.relations@interdigital.com
+1 (302) 300-1857

CAMBRIDGE, Mass., Nov. 11, 2026 (GLOBE NEWSWIRE) — Wave Life Sciences, Inc. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, today announced that Paul Bolno, MD, MBA, President and Chief Executive Officer, is scheduled to participate in an analyst-led fireside chat at the Jefferies Global Healthcare Conference in London on Wednesday, November 18, 2026 at 3:30 p.m. GMT / 10:30 a.m. ET.

A live webcast of this presentation can be accessed by visiting “Investor Events” on the Investors section of the Wave Life Sciences website: https://ir.wavelifesciences.com/events-publications/events. A replay of this presentation will be archived and available on the site for a limited time following the event.

About Wave Life Sciences
Wave Life Sciences (Nasdaq: WVE) is a biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health. Wave’s PRISM® platform combines multiple modalities, chemistry innovation, and deep insights in human genetics to deliver scientific breakthroughs that treat both rare and common disorders. Its toolkit of RNA-targeting modalities, including RNAi (SpiNA) and RNA editing (AIMers), provides Wave with unmatched capabilities for designing and sustainably delivering candidates that optimally address disease biology. Wave’s lead pipeline programs include obesity (WVE-007), alpha-1 antitrypsin deficiency (WVE-006), and PNPLA3 I148M liver disease (WVE-008), as well as several preclinical programs utilizing the company’s versatile RNA medicines platform. Driven by the calling to “Reimagine Possible,” Wave is leading the charge toward a world in which human potential is no longer hindered by the burden of disease. Wave is headquartered in Cambridge, MA. For more information on Wave’s science, pipeline and people, please visit www.wavelifesciences.com and follow Wave on X and LinkedIn.

Contact:
Kate Rausch
VP, Corporate Affairs and Investor Relations
+1 617-949-4827

Investors:
James Salierno
Director, Investor Relations
+1 617-949-4043
InvestorRelations@wavelifesci.com

Media:
Katie Sullivan
Senior Director, Corporate Communications
+1 617-949-2936
MediaRelations@wavelifesci.com

  • Focused: Positioned in markets with structural long-term demand
  • Repeatable: Projecting 10%+ organic revenue CAGR through 2029E, excluding megaprojects
  • Profitable: Targeting growth that converts to value through strong margins, cash generation and disciplined leverage

HOUSTON, Nov. 11, 2026 (GLOBE NEWSWIRE) — KBR (NYSE: KBR) will host its Investor Day today in New York City. Members of KBR’s leadership team will outline the company’s trajectory following the proposed spin-off of its Mission Technology Solutions business, which is expected to operate as Trinzic, Inc. in 2027. The presentation will include KBR’s strategic vision for the Sustainable Technology Solutions business, proven repeatable growth model, capital allocation framework and medium-term financial targets.

“Today’s Investor Day marks an exciting milestone as we present the next chapter for KBR,” said Stuart Bradie, chair of the KBR Board of Directors, president and CEO. “As we prepare for separation, we are aligning dedicated leadership and capital behind our repeatable model for sustained revenue growth, driven by early access to customer investment decisions, our customer-centric delivery approach and scalable execution. We believe our sharpened strategic focus, attractive end-market exposure and capital-light business model provide a powerful foundation for profitable growth, strong cash generation and long-term shareholder value creation.”

Investor Day Themes and Strategic Framework

The event theme, “Focused on what the future demands,” reflects how long-term investment in energy security and transition, infrastructure productivity and resilience, and food and fertilizer security is creating demand for KBR’s technology, advisory and delivery expertise. The presentation will highlight KBR’s repeatable growth model for turning this demand into profitable growth and strong cash generation:

  • Early Access: Shaping Decisions and Creating Opportunity
    • Proven credibility earns earlier access, giving KBR insight into customer needs before scope is defined and creating opportunities to shape solutions and expand what comes next.
  • Customer Platforms: Expanding Relationships and Growth Opportunities
    • Deep customer relationships and differentiated expertise provide a foundation to address evolving needs, earn a broader role with customers, and drive repeat business and long-term growth.
  • Scalable Execution: Delivering Profitable Growth
    • Local accountability, global expertise, proven knowledge and technology-enabled efficiency enable delivery at scale while maintaining quality, consistency and commercial discipline.

The model is supported by approximately $5.8 billion in backlog as of the third quarter of 2026, a $54 billion qualified opportunity pipeline, and a customer base that generates more than 75% of revenue from existing relationships. Together, these factors provide visibility into potential future demand and demonstrate KBR’s ability to earn repeat business and expand customer relationships over time.

Medium-term Financial Targets
The medium-term financial targets for KBR as a standalone business reflect a focus on profitable growth and strong cash generation:

  • Organic Revenue CAGR (2026E–2029E): 10%+
  • Adjusted EBITDA Margin1 (2027E–2029E): 12%+
  • Free Cash Flow Conversion1 (2027E-2029E): 85%+

These targets exclude contributions from megaprojects (greater than $1 billion in KBR scope) and future capital deployment opportunities, reflect current objectives rather than guidance, and are not guarantees of future performance.

Capital Allocation Framework

KBR’s capital allocation framework prioritizes investment in the core business, disciplined strategic M&A and shareholder returns, while targeting net leverage below 2.5 times trailing-twelve-month adjusted EBITDA, including M&A deployment.

Event Details and Presentation Materials

KBR’s Investor Day will begin today at 9 a.m. Eastern Time. In connection with the Investor Day presentation, accompanying presentation slides, which provide additional information on KBR’s strategy and medium-term financial targets, are now available at futuredemands.kbr.com/KBR-Investor-Day-Presentation and through the Investor Relations section of KBR’s website at investors.kbr.com. The live webcast can be accessed here: KBR Investor Day – webinar.net. A replay will be available through the same link shortly after the event concludes.

About KBR
KBR is a global technology and services company helping customers solve complex challenges across energy, industrial and critical infrastructure, and food and agriculture markets. Combining differentiated technology, engineering and operational expertise, and global delivery capabilities, KBR works across the asset lifecycle to help customers shape investments, deliver projects, and optimize operations. With approximately 16,000 employees across more than 30 countries, KBR is focused on delivering better outcomes for customers in markets critical to the world’s future.

Non-GAAP Financial Information
This press release includes certain non-GAAP financial measures. Because not all companies calculate non-GAAP financial measures identically (or at all), the presentations herein may not be comparable to other similarly titled measures used by other companies. Further, such non-GAAP financial information should not be considered superior to, as a substitute for or as an alternative to the historical financial information of the company, if any, prepared in accordance with GAAP.

Adjusted EBITDA Margin and Free Cash Flow Conversion
Adjusted EBITDA margin and free cash flow conversion are considered non-GAAP financial measures under SEC rules. Adjusted EBITDA is defined as Net income (loss) attributable to KBR, plus Net (income) loss from discontinued operations, net of tax; less Net income (loss) attributable to noncontrolling interest included in discontinued operations; less Interest expense; Other non-operating expense (income); Provision for income taxes; Depreciation and amortization (D&A); and certain discrete items as identified by Management to be non-recurring in nature. Adjusted EBITDA margin is calculated as Adjusted EBITDA divided by Revenues. Management believes adjusted EBITDA and adjusted EBITDA margin affords investors a view of what management considers KBR’s core performance.

Free cash flow is calculated as cash flows provided by operating activities less capital expenditures, and free cash flow conversion is calculated as free cash flow divided by adjusted net income. Management believes free cash flow conversion affords investors useful information regarding KBR’s cash generation and its ability to convert earnings into cash.

The Company does not provide a reconciliation of adjusted EBITDA and free cash flow conversion to the most comparable GAAP financial measures on a forward-looking basis because the Company is unable to predict with reasonable certainty the ultimate outcome of legal proceedings, unusual gains and losses, capital expenditures, and acquisition-related expenses without unreasonable effort, which could be material to the Company’s results computed in accordance with GAAP.

Forward-Looking Statements​

This release contains forward-looking statements regarding our plans, including the proposed separation of the Mission Technology Solutions business into an independent, publicly traded company, Trinzic, and our objectives, goals, strategies, investments, capital deployment, risk profile, program activity, backlog information, returns, capital requirements, future events, future financial performance, future demand expectations and other information that is not historical. When used in this release, the words “estimates,” “expects,” “anticipates,” “potential,” “projects,” “plans,” “intends,” “believes,” “forecasts,” “targets” or future or conditional verbs such as “will,” “should,” “could” or “may,” and variations of such words or similar expressions are intended to identify forward-looking statements. Because forward-looking statements relate to the future, they are subject to inherent risks, uncertainties and other factors that are difficult to predict, and which could cause actual results to differ materially from the forward-looking statements contained in this release. Our most recently filed Annual Report on Form 10-K, any subsequent Form 10-Qs and 8-Ks and other U.S. Securities and Exchange Commission filings discuss some of the important risk factors that the company has identified that may affect its business, results of operations and financial condition.

The proposed spin-off is currently targeted to be completed on January 4, 2027, subject to final approval by KBR’s board of directors and other customary conditions. The medium-term targets reflect our current objectives and do not constitute guidance. Forward-looking statements, including these targets, are not guarantees of future performance, and actual results and future developments may differ materially and adversely from those expressed or implied by such statements. The forward-looking statements in this release speak only as of the day of this release. Except as required by law, KBR undertakes no obligation to revise or update publicly any forward-looking statements for any reason.

For further information, please contact:

Investor Relations:
Rachael Goldwait
Vice President, Investor Relations
713-753-4634
Investors@kbr.com
Media Relations:
Caitlin Gardner
Director, Global Communications
713-753-3800
Mediarelations@kbr.com
   

1 As used throughout this release, adjusted EBITDA margin and free cash flow conversion are non-GAAP financial measures.  See additional information at the end of this release regarding non-GAAP financial information, including why reconciliations of these forward-looking measures to the most directly comparable GAAP measures are not provided.

VANCOUVER, British Columbia, Nov. 11, 2026 (GLOBE NEWSWIRE) — Conifex Timber Inc. (“Conifex”, “we” or “us”) (TSX: CFF) today reported results for the third quarter ended September 30, 2026.  EBITDA* was negative $5.7 million for the quarter compared to EBITDA of negative $6.3 million in the second quarter of 2026 and negative EBITDA of $16.6 million in the third quarter of 2025. Net loss was $7.9 million or ($0.19) per share for the quarter versus a net loss of $9.5 million or ($0.23) per share in the previous quarter and a net loss of $16.6 million or ($0.41) per share in the third quarter of 2025.

Selected Financial Highlights

The following table summarizes our selected financial information for the comparative periods. The financial information reflects results of operations from our two-line sawmill in Mackenzie, British Columbia (the “Mackenzie Mill”) and 36-megawatt biomass power generation plant in Mackenzie, British Columbia (the “Power Plant”).

Selected Financial Information        
(unaudited, in millions of dollars, except share and
exchange rate information)
Q3
2026
Q2
2026
Q3
2025
Sales      
Lumber – Conifex produced 0.0 19.0 26.4
By-products and other 0.6 1.2 4.9
Bioenergy 0.0 2.8 6.8
  0.7 23.0 38.2
Operating income (loss) (6.3) (7.8) (19.5)
EBITDA(1) (5.7) (6.3) (16.6)
Net income (loss) (7.9) (9.5) (16.6)
Basic earnings (loss) per share (0.19) (0.23) (0.41)
Diluted earnings (loss) per share (0.19) (0.23) (0.41)
Shares outstanding – weighted average (millions) 40.8 40.8 40.8
Diluted Shares (millions) 40.8 40.8 40.8
       
       
Reconciliation of EBITDA to net income (loss)      
Net income (loss) (7.9 (9.5 (16.6
Add:  Finance costs 3.3 3.1 4.4
         Amortization 0.5 1.5 3.1
         Deferred income tax expense (recovery) (1.6 (1.4 (7.5
EBITDA(1) (5.7 (6.3 (16.6

* In this release, reference is made to “EBITDA”. EBITDA represents earnings before finance costs, taxes, depreciation and amortization. We disclose EBITDA as it is a measure used by analysts and by our management to evaluate our performance. As EBITDA is not a generally accepted earnings measure under IFRS and does not have a standardized meaning prescribed by IFRS, it may not be comparable to EBITDA calculated by other companies. In addition, EBITDA is not a substitute for net earnings or cash flow, as determined in accordance with IFRS, and therefore readers should consider those measures in evaluating our performance.


Selected Operating Information    
  Q3
2026
Q2
2026
Q3
2025
Production – WSPF lumber (MMfbm)(2) 0.0 14.1 38.5
Shipments – WSPF lumber (MMfbm)(2) 0.0 23.6 40.1
Electricity production (GWh) 0.0 19.8 47.6
Average exchange rate – $/US$(3) 0.715 0.723 0.726
Average WSPF 2×4 #2 & Btr lumber price (US$)(4) $487 $488 $477
Average WSPF 2×4 #2 & Btr lumber price (CDN$)(5) $681 $675 $657

(1) Conifex’s EBITDA calculation represents earnings before finance costs, taxes, depreciation and amortization.
(2)  MMfbm represents million board feet.
(3) Bank of Canada, www.bankofcanada.ca.
(4)  Random Lengths Publications Inc.
(5)  Average WSPF 2×4 #2 & Btr lumber prices (US$) divided by average exchange rate.

Recent Developments

Mackenzie Mill and Power Plant Operations

We are advancing restart planning and expect to resume sawmill operations once the conditions necessary for a successful startup have been satisfied, including the availability of financing to fund such restart (including the remaining funding available under the LETL Loan (as defined herein)) and sufficient sawlog inventory. Power Plant operations resumed on November 10, 2026, and Mackenzie Mill operations are currently expected to resume in or about December 2026.

Summary of Third Quarter 2026 Results

Consolidated Net Earnings

During the third quarter of 2026, we incurred a net loss of $7.9 million or $0.19 per share compared to a net loss of $9.5 million or $0.23 per share in the previous quarter, and a net loss of $16.6 million or $0.41 per share in the third quarter of 2025. Our results for the current quarter reflect the curtailment of our Mackenzie Mill and Power Plant operations for the quarter.

The Mackenzie Mill remained curtailed throughout the third quarter of 2026 and, as a result, we did not produce any lumber in the quarter, compared to 14.1 million board feet produced in the previous quarter and 38.5 million board feet produced in the third quarter of 2025. Our planer mill was also idle during the quarter.

We shipped a nominal volume of Conifex-produced lumber in the third quarter of 2026, compared to 23.6 million board feet shipped in the previous quarter and 40.1 million board feet shipped in the third quarter of 2025, as finished lumber inventories were largely drawn down in the previous quarter. Finished lumber inventory at the Mackenzie Mill was approximately 0.3 million board feet at September 30, 2026.

Revenues from lumber products were nominal in the third quarter of 2026, compared to $19.0 million in the previous quarter and $26.4 million in the third quarter of 2025, reflecting minimal lumber shipments during the curtailment. By-product and other revenues were $0.6 million in the third quarter of 2026, consisting primarily of sawlog sales, compared to $1.2 million in the previous quarter and $4.9 million in the third quarter of 2025.

Cost of goods sold was $6.0 million in the third quarter of 2026, compared to $21.4 million in the previous quarter and $35.4 million in the third quarter of 2025. With no production in the quarter, cost of goods sold in the current quarter primarily reflects costs incurred while our operations were curtailed, including approximately $3.6 million at the Mackenzie Mill for fixed site costs, overhead, staffing and care and maintenance and approximately $2.4 million at our Power Plant, which conducted annual maintenance shutdown activities through the end of the quarter.

We did not expense any anti-dumping (“AD”) and countervailing duty (“CVD”) deposits in the third quarter of 2026 as we made no lumber shipments into the US, compared to $3.7 million in the previous quarter and $15.3 million in the third quarter of 2025, which included a non-cash export duty expense of $12.0 million related to the finalization of the sixth administrative review. In total, we have deposited US$49.4 million net of duty sales.

Bioenergy Operations

Our Power Plant did not generate electricity in the third quarter of 2026. The Power Plant entered its scheduled annual maintenance shutdown in May 2026 which was completed by the end of the quarter. Our Power Plant sold 19.8 GWh of electricity under our electricity purchase agreement with the British Columbia Hydro and Power Authority in the previous quarter and 47.6 GWh in the third quarter of 2025.

As we did not generate electricity in the third quarter of 2026, revenues from our bioenergy operations were nil in the quarter, compared to $2.8 million in the previous quarter and $6.8 million in the third quarter of 2025. The absence of electricity sales was the primary driver of the lower revenues in the current quarter.

Selling, General and Administrative Costs

Selling, general and administrative costs were $0.9 million in the third quarter of 2026, compared to $1.4 million in the previous quarter and $1.4 million in the third quarter of 2025. The decrease relative to both comparative periods primarily reflects cost-saving measures implemented during the curtailment. Selling, general and administrative costs in the third quarter are shown net of a refund of US$0.2 million ($0.3 million) of softwood lumber duties paid on a portion of 2017 shipments from Lignum Forest Products LLP (“Lignum”). Lignum was a wholly-owned subsidiary of Conifex during the 2017 period in which the duties were paid.

Finance Costs and Accretion

Finance costs and accretion totalled $3.3 million in the third quarter of 2026, compared to $3.1 million in the previous quarter and $4.4 million in the third quarter of 2025. The increase relative to the previous quarter primarily reflects higher borrowings, including advances under a second amended and restated credit agreement with Pender Corporate Bond Fund (“PenderFund”) in respect of its secured term loan supporting the lumber operations (the “PenderFund Term Loan”) and the secured term loan of up to $30 million under the Large Enterprise Tariff Loan program provided under a credit agreement entered into by Conifex with the Canada Enterprise Emergency Funding Corporation (“CEEFC”) (the “LETL Loan”) advanced in September 2026, together with the amortization of deferred financing costs. The decrease relative to the third quarter of 2025 reflects a non-cash interest adjustment of $1.9 million recorded in that quarter related to the finalization of duty rates under the sixth administrative review, partially offset by higher overall debt levels, including the $19.0 million secured term loan between Conifex Mackenzie Forest Products Inc., a wholly-owned subsidiary of Conifex, and the Business Development Bank of Canada under the Softwood Lumber Guarantee Program (the “BDC Loan”) drawn in March 2026.

Gain or Loss on Derivative Financial Instruments

From time to time, we may enter into lumber futures contracts to manage our commodity lumber price or foreign exchange exposures. Gains or losses on derivative instruments are recognized as they are settled or as they are marked to market for each reporting period.

There were no outstanding futures contracts in place as at September 30, 2026.

Foreign Exchange Translation Gain or Loss

The foreign exchange translation gain or loss recorded for each period on our statement of net income results from the revaluation of US dollar-denominated cash and working capital balances to reflect the change in the value of the Canadian dollar relative to the value of the US dollar. US dollar-denominated monetary assets and liabilities are translated using the period end rate.

The Canadian dollar averaged US$0.715 during the third quarter of 2026, representing a weakening relative to both the previous quarter and the third quarter of 2025.

The foreign exchange translation impacts arising from the variability in exchange rates at each measurement period on cash and working capital balances resulted in a minimal foreign exchange translation gain in the third quarter of 2026, compared to a translation loss of $0.1 million in the previous quarter and a translation loss of $0.2 million in the third quarter of 2025.

Income Tax

We recorded an income tax recovery of $1.6 million in the third quarter of 2026, compared to a recovery of $1.4 million in the previous quarter and a recovery of $7.5 million in the third quarter of 2025. The recovery in the current quarter reflects continued operating losses, while the recovery in the third quarter of 2025 primarily reflected the non-cash export duty expense related to the finalization of the sixth administrative review.

Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities on our balance sheet and the amounts used for income tax purposes. As at September 30, 2026, we have recognized deferred income tax assets of $27.4 million, compared to $25.9 million in the previous quarter and $13.1 million in the third quarter of 2025. Our deferred income tax asset increased relative to both comparative periods due to continued net losses in a challenging operating environment with elevated duties and tariffs and the curtailment of our operations.

Financial Position and Liquidity

Overall debt was approximately $122.5 million at September 30, 2026, compared to approximately $101.8 million at June 30, 2026, and $82.6 million at September 30, 2025. The increase in overall debt from the previous quarter was driven by the $19.8 million outstanding under the LETL Loan and net advances under the PenderFund Term Loan of approximately $1.0 million, partially offset by principal repayments on the secured term loan entered into in October 2018 among Conifex Power Limited Partnership, a wholly-owned subsidiary of Conifex, and a syndicate of private lenders (the “CPLP Term Loan”) and payments against leases. At September 30, 2026, we had $46.0 million outstanding on the CPLP Term Loan, $35.4 million outstanding on the PenderFund Term Loan, $19.8 million outstanding under the LETL Loan, $19.0 million outstanding under the BDC Loan, and $2.2 million in leases and other borrowings. The CPLP Term Loan is largely non-recourse to our lumber operations.

At September 30, 2026, we had available liquidity of $7.4 million, comprised of unrestricted cash. This is an increase from our available liquidity of $1.3 million as at June 30, 2026 and $1.7 million as at September 30, 2025. In addition, $10.2 million remained undrawn under the LETL Loan at September 30, 2026, the availability of which remains subject to the completion by Conifex of certain conditions, including evidence satisfactory to CEEFC that certain Mackenzie Mill restart milestones have been or will be met by specified dates. The increase in liquidity relative to the previous quarter primarily reflects the proceeds of the LETL Loan, partially offset by operating cash outflows during the curtailment, interest payments and financing costs.

Like other Canadian lumber producers, we were required to begin depositing cash on account of softwood lumber duties imposed by the US government in April 2017. Cumulative duties of US$49.4 million paid by us, net of certain prior sales of such deposits, since the inception of the current softwood lumber trade dispute remain held in trust by the US pending administrative reviews and the conclusion of all appeals of US decisions. We expect future cash flows could be adversely impacted by the AD and CVD duty deposits to the extent additional costs on US destined shipments are not mitigated by higher lumber prices.

Conifex recognizes there is material uncertainty that may cast significant doubt on Conifex’s ability to continue as a going concern but has concluded it is appropriate to prepare the consolidated financial statements on a going concern basis, which contemplates the realization of assets and settlement of liabilities in the ordinary course of business.

During the current year, Conifex’s financial results have been adversely impacted by duty and tariff increases imposed by the United States of America on softwood lumber imports. The uncertainty and impact of duties and tariffs related to generating positive cash flows from operations are unknown and indeterminable at this time. This has resulted in higher costs and reduced margins, creating uncertainty regarding future operating cash flows and profitability. After adjustments for working capital items, net cash outflow from operations was $8.8 million for the three months ended September 30, 2026.  Conifex did not expense any duty deposits over the three-month period as no lumber was shipped into the US. Net working capital at September 30, 2026 was $3.6 million as compared to negative $13.5 million as at June 30, 2026.

In September 2026, Conifex entered into the LETL Loan and completed amendments to each of the PenderFund Term Loan, the CPLP Term Loan and the BDC Loan, including the deferral of scheduled principal repayments until September 2028 (collectively, the “Lender Amendments”). These financings improved Conifex’s liquidity and financial flexibility. Conifex continues to work collaboratively with its lenders; however, there can be no assurance that any additional accommodations under its existing facilities or additional financing will be available on acceptable terms or at all.

At September 30, 2026, $10.2 million remained available under the LETL Loan, subject to the completion by Conifex of certain conditions, including evidence satisfactory to CEEFC that certain Mackenzie Mill restart milestones have been or will be met by specified dates. Conifex’s cash flow forecast indicates that, without access to these funds or other financing, Conifex would not have sufficient liquidity to fund its operations beyond December 2026. As at the date of this news release, Power Plant operations have resumed and Mackenzie Mill operations are currently expected to resume in or about December 2026. If the remaining funds under the LETL Loan are not available when required, Conifex would need to seek additional accommodations from its existing lenders or obtain alternative sources of financing, delay the restart of the Mackenzie Mill and/or implement further measures to reduce costs and preserve liquidity. There can be no assurance that the conditions to the remaining advance under the LETL Loan will be satisfied or that any such measures would be successful.

Conifex’s ability to continue as a going concern is dependent on the successful restart of the Mackenzie Mill, its ability to realize positive cash flows from operations, obtain additional financing from lenders (including accessing the remaining $10.2 million available under the LETL Loan) and maintain compliance with the terms, restart milestones and financial covenants of its loan agreements. The outcome of the foregoing, as well as ongoing trade negotiations and tariff policies, remains uncertain, and our ability to generate positive cash flows from operations is dependent on market prices for lumber, demand for Conifex’s products and/or increases in productivity resulting in higher volumes produced and lower costs, none of which can be assured.

Outlook

Market conditions for Canadian softwood lumber producers are expected to remain challenging through the remainder of 2026 and into 2027, shaped by a combination of macroeconomic uncertainty, evolving US housing demand, and ongoing trade dynamics.

Lumber prices softened through the third quarter of 2026, and volatility is likely to persist as supply adjusts to market conditions. Several producers have announced curtailments or reduced operating schedules, and further supply rationalization may be required to balance markets if demand recovery is slower than anticipated.

The final results of the seventh administrative review of the softwood lumber AD and CVD orders (“AR7”), published by the US administration in October 2026, reduced the combined AD and CVD cash deposit rate applicable to Conifex to 24.75% from 35.16% for shipments entered on or after October 19, 2026. The 10% tariff on Canadian lumber exported to the US, imposed under Section 232 of the Trade Expansion Act of 1962 (United States) since October 2025, continues to apply. During 2024, Conifex’s shipments were assessed cash deposits at weighted average rates of 6.79% (AD) and 3.60% (CVD). Because the final AR7 rates exceed the rates at which deposits were made on 2024 shipments, we estimate that we will recognize a non-cash export duty expense of approximately US$5.7 million ($8.1 million), together with accrued interest of approximately US$0.9 million ($1.3 million), in the fourth quarter of 2026. Trade uncertainty remains a significant factor for Conifex and we continue to monitor developments closely.

Following the entering into of the LETL Loan and the Lender Amendments, Conifex is advancing restart planning for the Mackenzie Mill. Mackenzie Mill operations are currently expected to resume in or about December 2026, once the conditions necessary for a successful startup, including sufficient sawlog inventory, have been satisfied. Power Plant operations resumed on November 10, 2026. Conifex remains focused on operational efficiency, disciplined capital allocation, and cost management to navigate current market conditions while positioning for potential improved pricing and demand as broader economic conditions normalize. Conifex’s near-term liquidity will depend on, among other things, the timing of the Mackenzie Mill restart and access to the remaining $10.2 million available under the LETL Loan, which is subject to certain conditions, including evidence satisfactory to CEEFC that certain Mackenzie Mill restart milestones have been or will be met.

Conference Call

We have scheduled a conference call on Wednesday, November 11, 2026, at 9:00 AM Pacific time / 12:00 PM Eastern time to discuss the third quarter 2026 financial and operating results. To participate in the call, please dial toll free 1-877-883-0383 and enter the participant Access ID: 2895745.

A transcript will be available upon request at investorrelations@conifex.com.

Our management’s discussion and analysis and financial statements for the quarter ended September 30, 2026, are available under our profile on SEDAR+.

For further information, please contact:   

Spencer Bell
Chief Financial Officer
(604) 216-2949

About Conifex Timber Inc.

Conifex and its subsidiaries’ primary business currently includes timber harvesting, reforestation, forest management, sawmilling logs into lumber and wood chips, and value added lumber finishing and distribution. Conifex’s lumber products are sold in the United States, Canadian and Japanese markets. Conifex also produces bioenergy at its power generation facility at Mackenzie, B.C.

Forward-Looking Statements

Certain statements in this news release may constitute “forward-looking statements.” Forward-looking statements are statements that address or discuss activities, events or developments that Conifex expects or anticipates may occur in the future. When used in this news release, words such as “estimates,” “expects,” “plans,” “anticipates,” “projects,” “will,” “believes,” “intends,” “should,” “could,” “may,” and other similar terminology are intended to identify such forward-looking statements. Forward-looking statements reflect the current expectations and beliefs of Conifex’s management. Because forward-looking statements involve known and unknown risks, uncertainties and other factors, actual results, performance or achievements of Conifex or the industry may be materially different from those implied by such forward-looking statements. Examples of such forward-looking information that may be contained in this news release include statements regarding: the availability and use of credit facilities or proceeds therefrom, including whether additional financing will be obtained on acceptable terms or at all; short-term and longer-term cash sufficiency; our level of liquidity and our ability to service our debt; the realization of expected benefits of completed, current and any contemplated capital projects and the expected timing and budgets for such projects, including the build-out of any high-performance computing or data center operations; the growth and future prospects of our business; our expectations regarding our results of operations and performance; our planned operating format and expected operating rates; the timing of, and satisfaction of conditions to, the restart of operations at our Mackenzie Mill and Power Plant; our perception of the industries or markets in which we operate and anticipated trends in such markets and in the countries in which we do business; our ability to supply our manufacturing operations with wood fibre and our expected cost of wood fibre; our expectation for market volatility associated with, among other things, the softwood lumber dispute with the U.S.; potential negative impacts of duties or other protective measures on our products, such as antidumping duties or countervailing duties on softwood lumber, or tariffs, duties or other protective measures on the Canadian economy in general; the potential for further escalating trade measures between Canada, the U.S. and other jurisdictions (including the applicability, timing and scope of any such measures); expected rates of such antidumping duties, countervailing duties, tariffs, and other duties imposed by the U.S. government, and any accounting entries required in respect thereof, including the expected financial impact of the final results of AR7; the outcome and/or effects of the U.S. government’s investigation into the national security implications of importing timber, lumber, and related products; continued positive relations with Indigenous groups; the development of a longer-term capital plan and the expected benefits therefrom; demand and prices for our products; our ability to develop new revenue streams; the outcome of any actual or potential litigation; future capital expenditures; changes in stumpage fees and the uncertainty regarding future timber availability and costs resulting therefrom; our expectations regarding interest rates and U.S. dollar benchmark prices; and weather conditions, natural and manmade disasters and climate change. Material factors or assumptions that were applied in drawing a conclusion or making an estimate set out in the forward-looking statements may include, but are not limited to, our future debt levels; that we will complete our projects in the expected timeframes and as budgeted; that we will effectively market our products; that capital expenditure levels will be consistent with those estimated by our management; our ability to obtain and maintain required governmental and community approvals; the impact of changing government regulations and shifting political climates; that demand for lumber and lumber prices will be consistent with our expectations; that transportation services by third party providers will continue uninterrupted; our ability to ship our products in a timely manner; that there will be no unforeseen disruptions affecting the operation of our Power Plant, that our Power Plant will continue to operate following its restart and that we will be able to continue to deliver power therefrom; that sufficient sawlog inventory will be available for the restart of our Mackenzie Mill and that sawmill operations will resume as expected; that the conditions to further advances under the LETL Loan, including the absence of any default and applicable Mackenzie Mill restart milestones, will be satisfied; that the export duty expense and accrued interest resulting from the final results of AR7 will not differ materially from our estimates; our ability to obtain financing on acceptable terms, or at all; that interest and foreign exchange rates will not vary materially from current levels; the general health of the capital markets and the lumber industry; and the general stability of the economic environments within the countries in which we operate or do business. Forward-looking statements involve significant uncertainties, should not be read as a guarantee of future performance or results, and will not necessarily be an accurate indication of whether or not such results will be achieved. A number of factors could cause actual results to differ materially from the results discussed in the forward-looking statements, including, without limitation: those relating to potential disruptions to production and delivery, including as a result of equipment failures, labour issues, the complex integration of processes and equipment and other similar factors; labour relations; failure to meet regulatory requirements; changes in the market; potential downturns in economic conditions; fluctuations in the price and supply of required materials, including log costs; fluctuations in the market price for products sold; foreign exchange fluctuations; trade restrictions or import duties, tariffs or other protective measures imposed by foreign governments; availability of financing (as necessary); and other risk factors detailed in our 2025 annual information form dated March 31, 2026 and our 2025 annual MD&A dated March 21, 2026 available under Conifex’s profile on SEDAR+ at www.sedarplus.ca and other filings with the Canadian securities regulatory authorities. These risks, as well as others, could cause actual results and events to vary significantly. Accordingly, readers should exercise caution in relying upon forward-looking statements and Conifex does not undertake any obligation to publicly revise them to reflect subsequent events or circumstances, except as required by applicable securities laws.

BOSTON, Nov. 11, 2026 (GLOBE NEWSWIRE) — Flywire Corporation (Nasdaq: FLYW) (“Flywire” or the “Company”), a global payments enablement and software company, today announced that the Company will be attending the following upcoming investor conferences:

  • On Tuesday, November 17, 2026, the Company will attend the Stephens Annual Investment Conference, NASH2026, in Nashville, TN. Cosmin Pitigoi, CFO, will participate in a fireside chat discussion which will begin at 11:00 am CST.
  • On Thursday, December 3, 2026, the Company will attend the 30th Annual UBS Global Technology and AI Conference in Scottsdale, AZ. Cosmin Pitigoi, CFO, will participate in a fireside chat discussion which will begin at 10:55 am MT.

The fireside chat discussion will be webcast live from Flywire’s investor relations website at https://ir.flywire.com/. A replay of the webcast will be available on the investor relations website for 90 days following the discussions.

About Flywire
Flywire is a global payments enablement and software company. We combine our proprietary global payments network, next-gen payments platform, and vertical-specific software to deliver the most important and complex payments for our clients and their customers.

Flywire leverages its vertical-specific software and payments technology to deeply embed within the existing A/R workflows for its clients across the education, healthcare, and travel vertical markets, as well as in key B2B industries. Flywire also integrates with leading ERP systems, such as NetSuite, so organizations can optimize the payment experience for their customers while eliminating operational challenges.

Flywire supports approximately 5,400** clients with diverse payment methods in more than 140 currencies across more than 240 countries and territories around the world. The company is headquartered in Boston, MA, USA, with global offices. For more information, visit www.flywire.com. Follow Flywire on X, LinkedIn , and Facebook

**Excludes clients from Flywire’s Sertifi and Invoiced acquisitions

Contacts
Investor Relations:
Masha Kahn
ir@flywire.com 

Media:
Sarah King
media@flywire.com

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.